Details for 2012857774

Up to date per 02.04.2026

Actions

Title / Product Name

BETULINDERIVATE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2012857774

EP Publication Number

2791103

E-Number

914271

Language

PCT Number

US12069637

Publication Date

22.10.2014 A

02.08.2017 B1

Registration Date

02.08.2017

AT Publication Date

15.08.2017

Application Date

14.12.2012

Registration Number

Priorities

16.12.2011

201161576448 P

IPC

C07C 69/753 20060101AFI20150405BHEP

Maximum Duration of Protection

14.12.2032

Owner

GlaxoSmithKline LLC251 Little Falls Drive19808 Wilmington DE US

Representative

Sonn & Partner PatentanwälteRiemergasse 141010 WienAT

Inventor

HATCHER, Mark Andrewc/o GlaxoSmithKline Global Patents Five Moore Drive PO Box 13398 Research Triangle Park, North Carolina 27709US

JOHNS, Brian, Alvinc/o GlaxoSmithKline Global Patents Five Moore Drive PO Box 13398 Research Triangle Park, North Carolina 27709US

MARTIN, Michael, Tolarc/o GlaxoSmithKline Global Patents Five Moore Drive PO Box 13398 Research Triangle Park, North Carolina 27709US

TABET, Elie, Aminec/o GlaxoSmithKline Global Patents Five Moore Drive PO Box 13398 Research Triangle Park, North Carolina 27709US

TANG, Junc/o GlaxoSmithKline Global Patents Five Moore Drive PO Box 13398 Research Triangle Park, North Carolina 27709US